Journal article
Cost-effectiveness of nodal observation versus completion lymphadenectomy in patients with melanoma and sentinel lymph node metastases.
Abstract
e22076
Background: The MSLT-II trial demonstrated no survival benefit of completion lymphadenectomy (CLND) compared to nodal observation (NO) and subsequent therapeutic lymphadenectomy (TLND) in the case of macroscopic nodal relapse in patients with melanoma and SLN metastases. NO avoids the upfront cost and morbidity of CLND. However, patients followed with NO must undergo intensive surveillance and if TLND is required, it is …
Authors
Parvez E; Dumitra T; Panagiotoglou D; Meterissian SH; Dumitra S
Journal
Journal of Clinical Oncology, Vol. 38, No. 15_suppl, pp. e22076–e22076
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2020
DOI
10.1200/jco.2020.38.15_suppl.e22076
ISSN
0732-183X